GOLDEN BIOTECHNOLOGY CORP.

 

Area: Pharmaceutical and Medical Devices

Booth No: R309

Website: https://www.goldenbiotech.com

 

Exhibitor Profile

 

Golden Biotechnology Corp. (GoldenBiotech)(4132.TWO), is a leading pharma. company. Antroquinonol is a NCE and distinguished from other developing drugs for COVID-19 by its oral design and multi-functions on anti-viral, anti-inflammation and anti-fibrosis and has been completed Phase 2 trial and unblinded. Granted by FDA Orphan Drug (ODD) for pancreatic cancer, AML and HCC. Pipeline: COVID-19, NSCLC, pancreatic cancer, AML, Alzheimer’s disease, hyperlipidemia, atopic dermatitis and hepatitis B.

 

Brands

 

Golden Biotechnology Corp. (GBC, GoldenBiotech)

 

Video

 

• 

  GoldenBiotech_Innovative & Breakthrough_COVID & Oncology

 

 

Exhibit Products

 

• 

  Antroquinonol ( HOCENA ), new oral drug clinical trial in Covid-19, AML, Lung Cancer, NSCLC, Pancreatic Cancer-Pandemic, Oncology

 

Exhibitor Press Release

 

• FDA Grants the Pre-EUA Meeting Request by GoldenBiotech’s Applied Antroquinonol to Treat COVID 2022-07-30
• Antroquinonol, Committed to Innovative & Breakthrough Therapy to Improve Quality of Life 2022-07-30
• 2022BioAsiaTaiwan-Golden Biotech Seminar Registration_Innovative Breakthrough_COVID-19 to Oncology 2022-07-27

 

 

 

back